Kenneth L. Davis, MD is the Executive Vice Chairman, Boards of Trustees of the Mount Sinai Health System in New York City, one of the nation’s largest integrated health systems, which includes the Icahn School of Medicine at Mount Sinai, eight hospitals, and more than 400 ambulatory sites. He is a leader in the move away from fee-for-service medicine to population health with the aim of keeping more patients healthy and out of the hospital. As a neurobiologist, Dr. Davis conducted pioneering research that led the FDA to approve four of the first five drugs for treating Alzheimer’s disease. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Davis is one of the most highly cited researchers in the field of brain diseases. His awards include the George H. W. Bush Lifetime of Leadership Award from Yale. In 2014 he was named a trustee of the Aspen Institute.

Chief Executive Officer
Professor and Kenneth L. Davis, MD, Distinguished Chair
Mount Sinai Health System

Chief Executive Officer, and Professor and Kenneth L. Davis, MD, Distinguished Chair, Mount Sinai Health System, is nationally recognized as a leader in academic medicine and health policy. Dr. Carr, who has practiced clinical emergency medicine for more than 20 years, is a renowned emergency physician and health policy researcher. He has focused on building regional systems of emergency care, especially for trauma, stroke, cardiac arrest, and sepsis, and developing innovative delivery system solutions to create a more distributed and accessible acute-care delivery system. He has served in an advisory role to domestic and international organizations and is a member of the National Academy of Medicine.

Chief Diversity Operations Officer, Mount Sinai Hospitals Group

Pamela Y. Abner, MPA, CPXP, is the Vice President and Chief Diversity Operations Officer for the Mount Sinai Hospitals Group. She has more than fourteen years of experience working with industry leaders to establish strategic and innovative programs for diversity, inclusion, and equity. Utilizing research methodologies, creating education curriculum, and applying best practices, she continuously seeks to help organizations identify discriminatory practices and disparities. A certified patient experience professional and unconscious bias educator, she focuses on eliminating barriers to care, employment, and education for underserved and underrepresented groups, and fostering relationships with community partners.

Ms. Abner received her bachelor’s degree from Brown University and master’s degree in Public Administration from Columbia University School of International and Public Affairs. A frequent presenter in national forums, she was named one of the Most Influential Women in Corporate America in 2019 by Savoy Magazine and a Notable Woman in Talent Resources by Crain’s New York Business in 2020.

Manish Arora, BDS, PhD, MPH, is the Edith J. Baerwald Professor of Environmental Medicine and Public Health and Vice Chairman of the Department of Environmental Medicine and Climate Science at the Icahn School of Medicine at Mount Sinai. A founding member of the Mount Sinai Institute for Exposomic Research, Dr. Arora serves as Director of its environmental exposure and precision environmental medicine laboratories, leading a team of more than 50 scientists who are advancing research in diseases that are national health priorities. Dr. Arora’s research focuses on the effects of prenatal and early life exposures on life-long health trajectories. In 2020, he and colleagues proposed the Biodynamic Interface Theory, a novel theoretical framework that explains how the environment interacts with physiology in a dynamic way over time. He is the founder and CEO of Linus Biotechnology, a company that uses innovative precision medicine approaches to bridge genomics and the environment to transform the way complex health conditions are diagnosed and treated. He the author of multiple books and the recipient of numerous prestigious awards.

Joshua B. Bederson, MD, is widely recognized as one of his generation’s leading brain tumor and cerebrovascular surgeons. Renowned for his pioneering work in leveraging digital visualization technologies within the operating room, Dr. Bederson’s leadership transformed surgical precision and patient outcomes through the integration of digital visualization tools, notably, augmented reality and microscope integration. He holds the prestigious positions of Leonard I. Malis, MD/Corinne and Joseph Graber Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai; Chair of Neurosurgery, and Artificial Intelligence and Human Health, Mount Sinai Health System; and Co-Founder and Executive Director of Mount Sinai BioDesign, where he has played a pivotal role in advancing surgical technology. His visionary guidance has positioned Mount Sinai BioDesign as a beacon of innovation, driving the development of state-of-the-art surgical technologies. Dr. Bederson is the co-principal investigator of a significant $11.6 million medical technology development grant from the New York City Economic Development Corporation, highlighting his commitment to advancing the field of surgery while fostering economic growth in the city. Driven by an unwavering dedication to his patients and a relentless pursuit of innovation, Dr. Bederson continues to shape the future of neurosurgery with compassion and ingenuity.

Isabelle Germano, MD is Professor, Neurosurgery, Neurology, and Oncological Sciences, Icahn School of Medicine at Mount Sinai and Director of the Comprehensive Brain Tumor Program; Co-Director of the Radiosurgery Program; and Vice Chair for Faculty Affairs and Diversity, Equity, and Inclusion in the Department of Neurosurgery. She established the school’s first multidisciplinary brain tumor program and directs two accredited fellowship programs. In her clinical practice, Dr. Germano cares for patients with brain and spine tumors using minimally invasive procedures. Her work includes pioneering first-in-human technology applications for computer-assisted, image-guided neurosurgery, and leading a first-in-human clinical trial in New York State using gene therapy for recurrent glioblastoma. Recognized nationally as a leader in brain tumor neurosurgery and internationally as an esteemed neurosurgery educator, Dr. Germano has received more than 50 awards, published six books and more than 200 peer-reviewed scientific publications, and has held leadership roles in numerous associations in her field.

Itai Kloog, PhD, is Professor, Environmental Medicine and Public Health, at the Icahn School of Medicine at Mount Sinai. Dr. Kloog is an exposure scientist and a specialist in geographic information science (GIS), with expertise in exposure assessment, environmental epidemiology, and geo statistical modeling. Specifically, his research includes developing exposure models for epidemiology studies, advanced spatial and geo-statistical analysis, GIS and remote sensing, and the evaluation of the adverse health effects of exposure to air pollution and temperature extremes. He has published multiple papers in recent years on assessing temporally and spatially resolved PM2.5 and air temperature exposures for epidemiological studies in the United States and globally.

Thomas J. Oxley, MBBS, PhD, BMedSc, FRACP, is a vascular and interventional neurologist and expert in brain computer interfaces. He is Associate Professor and Joint Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia, and Clinical Instructor in the Department of Neurosurgery, The Mount Sinai Hospital.

Dr. Oxley has performed more than 1,600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. He has published more than 100 internationally peer-reviewed articles in journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine, and The Lancet.

Dr. Oxley is the founding CEO of Synchron, a brain data transfer company based in Brooklyn, New York, and has raised more than $145 million in private funding and grants. Synchron is developing the leading endovascular implantable brain computer interface, StentrodeTM, a system that aims to provide a treatment for debilitating medical illnesses and enable patients to feel empowered by reconnecting online in ways that can dramatically improve their lives.

In 2022, Dr. Oxley and Synchron commenced an FDA-approved clinical trial on the Stentrode motor neuroprosthesis that is paving the way towards what would be the first FDA marketing approval for an implanted brain computer interface.

Co-Founding Director and Director of Clinical Programming, Mount Sinai Parenting Center
Assistant Clinical Professor, Pediatrics, Icahn School of Medicine at Mount Sinai

Aliza W. Pressman, PhD, is a developmental psychologist with nearly two decades of experience working with families and the health care providers who care for them. She is an assistant clinical professor at the Icahn School of Medicine at Mount Sinai Hospital and co-founding director of The Mount Sinai Parenting Center. Pressman is a certified mindfulness and meditation teacher from the Greater Good Science Center at University of California, Berkeley. She is the New York Times bestselling author of “The 5 Principles of Parenting: Your Essential Guide to Raising Good Humans,” and host of the “Raising Good Humans” podcast. Pressman holds an MA in Risk, Resilience and Prevention and PhD in developmental psychology from Columbia University Graduate School of Arts and Sciences.

Director of Rehabilitation Innovation, Mount Sinai Health System
Associate Professor of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai

David Putrino, PhD, is the Nash Family Director of the Cohen Center for Recovery from Complex Chronic Illness and a professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai in New York City. Since the beginning of the COVID-19 pandemic in 2020, Putrino has been recognized globally as a leading expert in the assessment, treatment, and underlying pathophysiology of Long COVID. His team has managed the care of over 3,000 people with Long COVID and published multiple peer-reviewed scientific papers on the topic. In 2019, he was named “Global Australian of the Year” for his contributions to health care.

Neurosurgeon at the Skull Base Surgery Center, The Mount Sinai Hospital
Scientific Director of Mount Sinai BioDesign
Assistant Professor, Neurosurgery, Icahn School of Medicine at Mount Sinai

Benjamin Rapoport, MD, PhD, MS, is a neurosurgeon at the Skull Base Surgery Center, The Mount Sinai Hospital, specializing in minimally invasive surgery; Scientific Director of Mount Sinai BioDesign, a medical device incubator at Mount Sinai; and Assistant Professor, Neurosurgery, at the Icahn School of Medicine at Mount Sinai. Dr. Rapoport has been developing brain–computer interface technology for nearly two decades. He is a co-founder and Chief Science Officer of Precision Neuroscience, where he oversees the design and development of the company’s products and surgical implantation techniques, and previously served on the eight-member co-founding team of Neuralink, a neurotechnology company developing implantable brain–computer interfaces. He authored 50 scientific publications and 40 patents, many related to brain-computer interfaces and other innovations in medical technology. Dr. Rapoport received master’s degrees in Physics from Harvard University and Mathematics from Oxford University; a PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology; and a Medical Degree from Harvard Medical School

Maayan Yitshak-Sade, PhD, MPH, is Associate Professor, Environmental Medicine and Climate Sciences, Icahn School of Medicine at Mount Sinai, and member of the Mount Sinai Institute for Climate Change, Environmental Health, and Exposomics. An epidemiologist with a primary research interest in environmental health, Dr. Yitshak-Sade centers her research program on the interrelationship between multiple environmental and built environment exposures, including climate and air pollution, and cardiometabolic health. She investigates the complex health effects of exposure mixtures in large-scale cohorts using novel satellite-based exposure models, and the varying impacts of air pollutant mixtures on morbidity, mortality, and life expectancy across demographic and socioeconomic population groups in the United States and abroad. Dr. Yitshak-Sade received a Bachelor of Nursing, a Master’s in Public Health, and a PhD in Epidemiology, all from Ben-Gurion University, Beer-Sheva, Israel, and completed a postdoctoral fellowship at the Harvard T.H. Chan School of Public Health.